REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gammapharma Plus S.R.O. (Slovakia)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Gammapharma Plus S.R.O. Profile Updated: October 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Gammapharma Plus S.R.O. is an enterprise based in Slovakia. Its main office is in Nitra. The enterprise operates in the Marketing Research and Public Opinion Polling industry. The company was established on February 26, 2011. From the latest financial highlights, Gammapharma Plus S.R.O. reported a net sales revenue drop of 2.17% in 2023. Its’ total assets recorded a negative growth of 22.71%. Gammapharma Plus S.R.O.’s net profit margin decreased by 2.48% in 2023.

Headquarters
Hornocermanska, 4
Nitra; Nitriansky; Postal Code: 94901

Contact Details: Purchase the Gammapharma Plus S.R.O. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gammapharma Plus S.R.O. report to view the information.
Registered Capital:
Purchase the Gammapharma Plus S.R.O. report to view the information.
Incorporation Date:
February 26, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Gammapharma Plus S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.17%▼
Total operating revenue
-14.58%▼
Operating profit (EBIT)
-11.73%▼
EBITDA
-18.25%▼
Net Profit (Loss) for the Period
-7.86%▼
Total assets
-22.71%▼
Total equity
-23.64%▼
Operating Profit Margin (ROS)
-5.28%▼
Net Profit Margin
-2.48%▼
Return on Equity (ROE)
6.22%▲
Quick Ratio
-10.54%▼
Cash Ratio
-10.15%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo